First Eagle Investment Management, LLC Gsk PLC Transaction History

First Eagle Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $1.02 Million - $1.16 Million	24,354 Added 40.99%	83,763 $3.65 Million
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $716,697 - $850,488	17,815 Added 42.83%	59,409 $2.59 Million
Q4 2021 Feb 10, 2022	BUY	$38.88 - $45.31 $892,451 - $1.04 Million	22,954 Added 123.14%	41,594 $1.83 Million
Q3 2021 Nov 10, 2021	BUY	$38.79 - $43.16 $284,679 - $316,751	7,339 Added 64.94%	18,640 $712,000
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $389,120 - $441,756	10,655 Added 1649.38%	11,301 $450,000
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $11,034 - $12,883	322 Added 99.38%	646 $23,000
Q4 2020 Feb 10, 2021	BUY	$34.07 - $39.94 $11,038 - $12,940	324 New	324 $12,000
Q1 2018 May 04, 2018	SELL	$36.18 - $40.15 $36 - $40	-1 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$39.44 - $41.55 $39 - $41	1	1 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.